May 2010, Vol 3, No 3, SPECIAL ISSUE
issuu.com/ahdbonline/docs/acc_2010?mode=embed&layout=http%3A%2F%2Fskin.issuu.com%2Fv%2Flight%2Flayout.xml&showFlipBtn=true
">TABLE OF CONTENTS | View Digital Edition
Presidential Address Focused on Patient- Centered Care
Applying Comparative Effectiveness Research in Cardiology
Atrial Fibrillation Annual National Costs Estimated at $26 Billion
What Will Healthcare Reform Look Like? Policy Experts Offer Perspectives on Cost-Containment, Government Control
HEALTH ECONOMICS
Economic Analysis of ACTIVE-A
Practice Innovation Can Reduce Cost, Enhance Quality
Statin Prophylaxis Cost-Effective for People with Low LDL-C and Elevated CRP
Postdischarge HF Management Reduces Costs
Patient’s Financial Burden May Affect Outcomes Post-MI
COMPARATIVE EFFECTIVENESS RESEARCH
Events Post-PCI More Frequent with Public Insurance
Ticagrelor Confers Superior Survival in CABG Surgery Compared with Clopidogrel
Still No Answer on Safety, Efficacy of Drug- Eluting versus Bare Metal Stents for Acute MI
Catheter Therapy for Mitral Valve Repair Safer than Surgery
Less-Invasive Treatment Post-MI May Explain 50% Excess Mortality in Women than in Men
CABANA: Ablation versus Drug Therapy for Complex Atrial Fibrillation
HYPERTENSION
Angioedema Risk 50% Higher with ACE Inhibitors than with ARBs
Rethinking Aggressive Blood Pressure Control in Diabetes
High Calcium Channel Blockers Discontinuation Rate Caused by Pedal Edema
PERSONALIZED MEDICINE
Genotyping Improves Warfarin Therapy, Reduces Costs
Genetic Variant Affects Response to Clopidogrel
Genomic Analysis Coming Soon to a Laboratory Near You
CARE: Genotyping Can Identify Which Patients Will Respond to Statins
DIABETES AND CVD
Fenofibrate plus Statin No Better than Statin Alone in Diabetes
NAVIGATOR: Lifestyle Modification Still Best Strategy to Prevent Diabetes
ACC.10 HIGHLIGHTS
In a Shift, Women Referred More Often for Cardiac Catheterization after Noninvasive Testing
Regenerative Medicine for Cardiologists: Advances and Challenges Low Vitamin D Prevalent in MI Patients
Novel Anticoagulant Safe and Well-Tolerated